Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Editorial Office
- 30th Anniversary
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
23 September 2022
Recruiting Reviewer Board Members for Current Oncology
We are now recruiting Reviewer Board Members (RBMs) for the journal Current Oncology (ISSN: 1718-7729). If you are an active researcher in the field and are passionate about publishing cutting-edge research, do not hesitate to contact the Current Oncology Editorial Office ([email protected]).
Current Oncology is an international, peer-reviewed, and open access journal that represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is indexed by Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and other databases. The 2021 Impact Factor of Current Oncology is 3.109, and the CiteScore is 3.5.
The benefits of joining our Reviewer Board are as follows:
- For each review, you will receive a discount voucher that can be used for reducing the article processing charge (APC) of a future submission to any MDPI journal;
- You may publish one paper per year with a 20% discount after standard peer-review in Current Oncology;
- You will be considered for the journal’s Outstanding Reviewer Award;
- You will receive a personalized reviewer certificate;
- You will have the ability to adjust your review frequency based on your schedule in our system;
- You can verify and showcase your peer-review and editorial contributions for our journal.
If you have any questions, suggestions, or recommendations, do not hesitate to let us know. We look forward to working with you.
Current Oncology Editorial Office